not vested
<Research Report> BIOSTIME (01112.HK) initiated Buy with target $59 by BofA Merrill Lynch
In the latest research report, BofA Merrill Lynch initiated the Buy rating for BIOSTIME (01112.HK), with target price $59, representing 2015 forecast P/E of 21.5 times, as the Bank sees the effective channel strategy and O2O initiative, the potential to become all-around baby product provider, coupled with the management power and solid past results.
Source: AAStocks Financial News